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Tausta: Äkillinen sydämen tilavuusriippuvainen ylikuormitus voi johtua sydämen eteisväliseinän 
äkillisesti repeytymisestä; tilanne on potilaalle hengenvaarallinen ja huomattava haaste hoidollisesti. 
Äkillinen sydämen tilavuusriippuvainen ylikuormitus altistaa sydämen vajaatoiminnalle. 
Tilavuusriippuvaisen ylikuormittumisen aiheuttama äkillinen oikean kammion venyttyminen voi 
johtaa laajaan sydänvaurioon. Tutkimme kokeellisesti vaikuttaako kirurgisesti luotu sydämen 
tilavuusriippuvainen ylikuormittaminen sydänlihakseen jo varhaisessa vaiheessa. Lisäksi tutkimme 
joitakin vauriomerkkiaineita edellä mainitussa tilanteessa. 
 
Metodit: 34:lle geneettisesti identtiselle Fisher -kantaiselle rotalle aiheutettiin sydämen äkillinen 
tilavuuskuormitus aortta-alaonttolaskimon välisen aukileen avulla. Sydämet preparoitiin talteen 
joko yhden tai kolmen vuorokauden kuluttua histologista tutkimusta varten. Seuraavien geenien 
ilmenemistä tutkittiin sydänlihasvaurion selvittämiseksi: atrial natriuretic peptide (ANP), matrix 
metalloproteinaasi 9 (MMP9), transforming growth factor β (TGFβ) ja kitinaasi-3-kaltainen 
glykoproteiini (YKL40).  
 
Tulokset: Iskeemisten intramyokardiaalisten valtimoiden suhteellinen lukumäärä kasvoi 
tilavuuskuormitteisilla sydämillä kammioväliseinässä verrattuna kontrolleihin yhden ja kolmen 
vuorokauden kohdalla (0.16 ± 0.02 vs. 0.02 ± 0.01, point score unit (PSU), p = 0.002 ja 0.14 ± 0.02 
vs. 0.02 ± 0.01, PSU, p = 0.009) samoin kuin vasemmassa kammiossa kolmannen päivän kohdalla  
(0.11 ± 0.02 vs. 0.04 ± 0.01, PSU, p = 0.007). Viitaten varhaiseen sydänlihasvaurioon ANP (p = 
0.019) lisääntyi odotetusti tilavuuskuormitteisilla sydämillä kontrolleihin verrattuna yhden päivän 
kohdalla. MMP9 (p = 0.003 ja p = 0.006), TGFβ (p = 0.002 ja p = 0.004) ja YKL40 (p = 0.001 ja p 
= 0.003) geeniekspressiot lisääntyivät yhden ja kolmen päivän kohdalla tilavuuskuormitteisilla 
sydämillä yhdessä lisääntyneen sydänlihaksen sisäisen makrofagi-infiltraation kanssa. Nämä 
löydökset tukevat teoriaamme jonka mukaan vaihtoehtoisesti aktivoituneet makrofagit 
myötävaikuttavat äkillisen tilavuuskuormituksen jälkeen sydämen patofysiologiassa. 
 
Pohdinta: Kirurgisesti aiheutettu sydämen äkillinen tilavuuskuormitus johtaa varhaiseen 
hapenpuutteesta aiheutuvaan sydänlihasvasteeseen, joka on havaittavissa sydänlihaksen sisäisissä 
pienissä valtimoissa. Tässä tutkimuksessa sydämen muovautumiseen liittyvien varhaisten 
avainmuuttujien ilmeneminen vahvistaa käsitystä varhaisen sydämen vajaatoiminnan kehittymisestä 
tilavuuskuormituksen jälkeen. 
 
 
Avainsanat: äkillinen tilavuuskuormitus, sydänlihaksen valtimot, rotta, YKL40 
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ABSTRACT 
 
Background: Acute volume-overload (AVO) predisposes to cardiac failure. Global cardiac injury 
may ensue after acute right-sided distension of the heart due to AVO. We experimentally 
investigated whether surgical AVO impacts early on the myocardium and some markers of injury.  
Methods: Thirty-four syngeneic Fisher rats underwent surgical abdominal aortocaval fistula to 
induce AVO. The hearts were procured for regional and quantitative histology after one and three 
days. Gene expressions for atrial natriuretic peptide (ANP), matrix metalloprotease 9 (MMP9), 
transforming growth factor β (TGFβ) and YKL40 were investigated for myocardial injury.  
2Results: The relative number of ischemic intramyocardial arteries were abundant in the septum of 
the hearts with AVO compared with controls at day 1 and 3 [0.16 ± 0.02 vs. 0.02 ± 0.01, point score 
unit (PSU), p = 0.002 and 0.14 ± 0.02 vs. 0.02 ± 0.01, PSU, p = 0.009, respectively] followed by 
similar changes in the left ventricle at day 3 (0.11 ± 0.02 vs. 0.04 ± 0.01, PSU, p = 0.007). 
Indicating early myocardial injury, ANP (p = 0.019) was increased in AVO hearts as compared with 
controls at day 1, as expected. More interestingly, MMP9 (p = 0.003 and p = 0.006), TGFβ (p = 
0.002 and p = 0.004) and YKL40 (p = 0.001 and p = 0.003) expressions were significantly 
increased at day 1 and 3, along with macrophage infiltration into the myocardium supporting the 
role of factors produced by alternatively activated macrophages in the pathogenesis of AVO-
induced pathophysiology in the heart.  
Conclusions: Surgical AVO induces an early ischemic myocardial response observed in the 
intramyocardial arteries. Early expression of key parameters of cardiac remodeling suggest for the 
onset of early cardiac failure after AVO. 
 
 
INTRODUCTION  
 
The presence of acute volume-overload (AVO) and subsequent acute right-sided heart insufficiency 
are associated with a dismal outcome after cardiac surgery.1,2 Devastating cardiac entities ensue due 
to increased cardiac oxygen consumption often despite corrective surgery,3 and there is 
increasing awareness of the prognostic significance of right-sided heart congestion during 
AVO and acute cardiac failure.4 Low coronary perfusion pressure associated with acute 
right-sided heart congestion after surgery has been reported to be responsible for early 
myocardial ischemia, inflammation and cardiac remodeling.5  
The development of global cardiac injury may ensue upon acute distension of the right side 
of the heart during AVO. Increased myocardial stretching of the right atrium and ventricle 
due to AVO may reflect the onset of irreversible cardiac failure. Therefore, it is vital to 
investigate the early phase of injury associated with AVO after surgery to understand the 
3main pathogenesis responsible for irreversible cardiac failure. We hypothesized that surgical 
AVO induces early ischemic changes in the intramyocardial arteries that nourish the 
vulnerable myocardium, eventually leading to global cardiac insufficiency.  
We developed a rat model simulating AVO induced by surgery by performing a surgical 5 
mm long abdominal aortocaval fistula. The aim of this study was to investigate the 
histology and gene expressions associated with acute myocardial changes after experimental 
AVO.  
 
 
MATERIALS AND METHODS  
 
Rats  
Thirty-four Fischer 344 rats (F344/NHsd, Harlan Laboratories, The Netherlands) weighing 200-350 
g underwent surgical abdominal arterial-venous fistula to induce AVO. In addition, six rats without 
AVO or surgery served as controls. The rats received humane care in compliance with the 
“Principles of Laboratory Animal Care” formulated by the National Society for Medical Research 
and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of 
Laboratory Animal Resources and published by the National Institutes of Health (NIH publication 
No. 86-23, revised 1996). The study was approved by the State Provincial Office.  
 
Surgical procedure  
Rats were anesthetized with sevoflurane (Baxter, USA) via inhalation and pentobarbiturate 
(Mebunat vet®; Orion Espoo, Finland; 50 mg/kg) intraperitoneally. The abdominal cavity was 
surgically opened, and the inferior vena cava and aorta were exposed. An arterial-venous fistula was 
performed intra-abdominally by incising vertically 5 mm both the abdominal aorta and the adjacent 
inferior vena cava, and joining these vessels surgically with a 7-0 running vascular suture. After 
surgery, 100 U Heparin Leo, (Vianex S.A., Greece) was administered i.v. From the abdominal 
4aorta, oxygenated blood was introduced into the abdominal vena cava, thus resulting in AVO of the 
heart. This model allowed us to study the impact of surgically-induced extensive AVO and 
associated myocardial changes in-vivo. The model thus simulated the clinical concept of volume-
overload without ischemia but with surgically-induced inflammation. After the procedure, 
buprenorfin (Vetergesic®; Orion Espoo, Finland; 0.1 mg/100 g) and carprofen (Norocarp®; 
Norbrook Laboratories Limited, Newry, Northern Ireland; 0.5 mg/100 g) were given 
subcutaneously for pain relief. 
 
Tissue samples 
The rats were sacrificed one (n = 23) or three (n = 7) days after AVO, while four rats were lost due 
to acute cardiac failure. The basal part of the hearts was separated and stored in RNAlater (Applied 
Biosystems, CA, USA) for quantitative reverse-transcription polymerase chain reaction (qRT-PCR) 
analysis. The apex part of the heart was fixed in formalin and embedded in paraffin. 
 
Histology 
For histology, 5-µm sections were cut and stained with Hematoxylin and Eosin. The following 
variables were evaluated from all of the samples: presence of myocardial edema, hemorrhage and 
ischemia. As vacuolization of nuclei in the media layer of intramyocardial arteries reflects edema, a 
representative cross-sectional intramyocardial artery was chosen randomly from both the left 
anterior, septum and right posterior ventricular walls. Normal, vacuolated and sharp-edged media 
cell nuclei were manually counted separately. The relative number of ischemic nuclei of 
intramyocardial arteries was calculated by dividing the total number of sharp-edged media cell 
nuclei by normal round-shaped nuclei. The presence of periadventitial inflammatory cells was 
graded according to an arbitrary scale from 0 to 1: 0, no inflammation; 1, presence of inflammation. 
Evaluation of the histology was performed by two investigators (Christa Huuskonen and Robin 
Bolkart) blinded to the study protocol. 
 
 
5Immunohistochemistry for CD68 
Immunohistochemistry was performed using Ventana Lifesciences Benchmark XT ® Staining 
module (Roche Group, Tucson, Arizona, USA). The paraffin-embedded slides were deparaffinized 
with three changes of xylene, rehydrated in a series of graded ethanol, and rinsed well under 
running distilled water. The slides were placed in a preheated retrieval buffer containing 0.1 mmol 
EDTA, pH 8.0, for 30 minutes, then cooled in the buffer for 5 minutes, followed by a 5-minute 
rinse under running distilled water. After heat-induced epitope retrieval, the slides were placed on 
an autostainer (DAKO Corp, Carpinteria, California, USA). The sections were incubated with 3% 
hydrogen peroxide in ethanol for 5 minutes to inactivate the endogenous peroxides and incubated in 
CD68 antibody (dilution 1:100) (Biomedica Gruppe, Vienna, Austria) for 30 minutes, followed by 
rinsing with Tris-buffered saline solution with Tween 20 (TBST) wash buffer. Secondary 
incubation was performed with DUAL-labeled polymer-horseradish peroxidase (K4061; DAKO 
Corp) for 15 minutes, and the slides were rinsed with TBST wash buffer. The sections were then 
incubated in 3,3-diaminobenzidine (K3467, DAKO Corp) for 5 minutes, counterstained with 
modified Schmidt hematoxylin for 5 minutes, and rinsed for 3 minutes in tap water to blue sections, 
dehydrated with graded alcohols, and cleared in three changes of xylene before mounting. 
Positively-stained CD68 deposition was assessed in a representative cross-sectional intramyocardial 
artery chosen randomly from the left anterior ventricular wall, right ventricular wall and septum. 
The total amount of myocardial CD68 deposition was calculated accordingly and expressed as PSU. 
The evaluation was performed by two investigators (Robin Bolkart and Veera Kähönen) blinded to 
the study protocol. 
 
qRT-PCR analysis 
Frozen tissue samples of the base of the heart of six randomly chosen hearts from each group were 
homogenized and RNA extraction was carried out with a GenEluteTM Mammalian Total RNA 
Miniprep kit (Sigma-Aldrich, St.Louis, MO, USA) with proteinase K treatment. Total RNA was 
then reverse-transcribed to cDNA using TaqMan® Reverse Transcription reagents and random 
hexamers (Applied Biosystems, Foster City, CA, USA). The cDNA obtained from the RT reaction 
(amount corresponding to approximately 1 ng of total RNA) was subjected to quantitative PCR 
using QuantiTect® Primer Assays (Qiagen, Valencia, CA, USA) for atrial natriuretic peptide 
(ANP), matrix metalloprotease 9 (MMP9), transforming growth factor β (TGFβ), chitinase 3-like 
6protein (YKL40) and GAPDH, Maxima® SYBR Green/ROX qPCR Master Mix (Thermo 
Scientific, Waltham, MA, USA), and an ABI PRISM 7000 Sequence detection system (Applied 
Biosystems, Foster City, CA, USA). The PCR reaction parameters for SYBR® Green detection 
were as follows: incubation at 50 °C for two minutes, incubation at 95 °C for 10 minutes, and 
thereafter 40 cycles of denaturation at 95 °C for 15 seconds and annealing and extension at 60 °C 
for one minute. Each sample was determined in duplicate. Ct values were determined, and the 
relative quantification was calculated using the 2-∆∆Ct method.6 We selected a variety of parameters 
associated with cardiac insufficiency. ANP reflects cardiac insufficiency. MMP9, TGFβ and 
YKL40 represent tissue remodeling due to ischemia reperfusion injury. The values of six controls 
were used as a calibrator, and the expression levels of ANP, MMP9, TGFβ and YKL40 were 
normalized against GAPDH. 
 
Statistical analysis 
Data are presented as mean ± standard error of the mean (SEM). Statistical analyses were 
performed with SPSS statistical software version 22.0 (SPSS Inc., Chicago, IL). Nonparametric 
data were analyzed between groups using Kruskal-Wallis and Mann-Whitney U tests. A p-value < 
0.05 was considered to be statistically significant. 
 
 
RESULTS  
 
Histology  
The absolute numbers of normal, ischemic and vacuolated medial cell nuclei of intramyocardial 
arteries of the heart with AVO and the controls are shown in Table 1. The absolute number of 
ischemic nuclei in the intramyocardial arteries was increased in the septum of the hearts with AVO 
at day one and day three compared with the controls (5.89 ± 1.12 and 5.80 ± 1.07, vs. 0.80 ± 0.37, 
PSU, p = 0.002 and p = 0.009, respectively, Figure 1). The absolute number of ischemic nuclei in 
the intramyocardial arteries was also increased in the left ventricle of the hearts with AVO at day 
7three compared with the controls (6.43 ± 1.25, vs. 1.60 ± 0.25, PSU, p = 0.004). There were no 
significant differences in the presence of subendocardial and myocardial edema, hemorrage, 
myocardial inflammation and ischemia of the left and right ventricles between the hearts with AVO 
and the controls at day one.  
 
Table 1. Histology of media cell nuclei of intramyocardial arteries of the hearts with acute volume-
overload (AVO) at one and three days compared with Controls 
 
 
  
Controls 
 
AVO day 1 
Mann-
Whitney 
U test 
p-value 
 
AVO day 3 
Mann-
Whitney 
U-test 
p-value 
Kruskall-
Wallis 
test 
p-value 
Right ventricle       
Normal nuclei 28.60±3.28 33.09±3.25 0.589 43.00±8.82 0.197 0.206 
Ischemic nuclei 1.60±1.03 3.26±0.64 0.170 3.33±0.62 0.153 0.256 
Vacuolated nuclei 3.60±1.25 4.48±1.10 0.831 0.67±0.42 0.039 0.057 
Left ventricle       
Normal nuclei 42.40±7.31 48.27±3.83 0.435 60.43±4.71 0.166 0.125 
Ischemic nuclei 1.60±0.25 4.45±1.09 0.120 6.43±1.25 0.004 0.016 
Vacuolated nuclei 6.20±2.15 5.68±2.37 0.208 0.71±0.29 0.012 0.040 
Septum       
Normal nuclei 28.60±5.04 38.78±4.54 0.332 43.80±6.83 0.117 0.387 
Ischemic nuclei 0.80±0.37 5.89±1.12 0.002 5.80±1.07 0.009 0.008 
Vacuolated nuclei 2.80±1.50 5.94±1.54 0.306 0.80±0.37 0.386 0.062 
 
Mann-Whitney U-test and Kruskall-Wallis test p-values. Values are expressed as mean ± standard 
error of mean. 
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Figure 1. Representative histology of a septal intramyocardial artery of a heart without AVO 
(Control; A), and hearts with acute volume-overload one day (AVO 1 day; B) and three days (AVO 
3 days; C) after surgery. X40. Note increased dark ischemic nuclei of the media in B and C 
(arrows).  
 
As shown in Figure 2, at day one, the relative number of ischemic nuclei of the 
intramyocardial arteries was abundant in the septum of the hearts with AVO compared with 
the controls (0.16 ± 0.02 vs. 0.02 ± 0.01, PSU, p = 0.002), while it did not differ 
significantly in the right and left ventricles (0.10 ± 0.02 vs. 0.05 ± 0.03, PSU, p=0.206 and 
0.09 ± 0.02 vs. 0.04 ± 0.01, PSU, p = 0.075, respectively). At day three, the relative number 
of ischemic nuclei of the intramyocardial arteries was increased in the septum and the left 
ventricle of the hearts with AVO compared with the controls (0.14 ±0.02 vs. 0.02 ± 0.01, PSU,  
p = 0.009 and 0.11 ± 0.02 vs. 0.04 ± 0.01, PSU, p = 0.007, respectively), while it did not differ 
significantly in the right ventricle (0.10 ± 0.04 vs. 0.05 ± 0.03, PSU, p = 0.230).  
 
 
 
9Figure 2. Relative ischemia of intramyocardial arteries of the septum (A), right ventricle (B) and 
left ventricle (C) of hearts without AVO (Controls, white triangles), hearts with acute volume 
overload one day (black circles) and three days after surgery (black boxes). *p < 0.05, Mann-
Whitney. Horizontal bars indicate mean. 
 
Immunohistochemistry for CD68 
At day three (Figure 3), the number of CD68-positive cells in the septum was increased in the hearts 
with AVO compared with the controls (2.33 ± 0.66 vs. 0.20 ± 0.20, PSU, p = 0.027), whereas there 
were no statistically significant differences in the right or left ventricles between the AVO hearts 
and the controls (2.83 ± 0.91 vs. 1.00 ± 0.31, PSU, p = 0.135 and 3.83 ± 1.07 vs. 1.20 ± 0.37, PSU, 
p = 0.079, respectively). 
10
Figure 3. Representative immunohistochemistry for CD68 deposition of a heart without AVO 
(Control; A) and a heart with acute volume-overload (AVO; B) three days after surgery. X40. Note 
positive CD68 staining (arrows) in B associated with periadventitial inflammation of a septal 
intramyocardial artery.
11
 qRT-PCR analysis  
At day one, the gene expression of ANP was increased in the hearts with AVO compared with the 
controls (2.64 ± 0.57 vs. 1.00 ± 0.22, FC, p = 0.019), as expected. Interestingly, the expressions of 
MMP9, TGFβ and YKL40 were significantly increased in the hearts with AVO both at day one and 
day three compared with the controls, with YKL40 showing more than a 10-fold increase at day one 
(Table 2).  
 
Table 2. Gene expression of hearts with AVO at one and three days compared with Controls 
  
Controls 
 
AVO day 1 
Mann-
Whitney 
U- test 
p-value 
 
AVO day 3 
Mann-
Whitney 
U-test 
p-value 
Kruskall
-Wallis 
test 
p-value 
 
ANP 1.00±0.22 2.64±0.57 0.019 2.08±0.66 0.165 0.055 
MMP9 1.00±0.39 9.64±2.33 0.003 5.84±1.37 0.006 0.005 
TGFβ 1.00±0.12 4.06±0.80 0.002 2.96±0.33 0.004 0.003 
YKL40 1.00±0.26 10.79±1.70 0.001 3.91±0.60 0.003 0.001 
 
Values are expressed as mean ± standard error of mean. ANP=atrial natriuretic peptide, 
MMP9=matrix metalloproteinase 9, TGFβ (tumor growth factor β), YKL40=chitinase 3-like 
protein  
 
 
 
DISCUSSION  
 
This study showed that surgical AVO induced acute myocardial ischemia of the right and left 
ventricles, preceded by septal changes. The absolute number of ischemic nuclei in the 
intramyocardial arteries were increased initially in the septum, and later, in the left ventricle. 
Accordingly, the relative number of ischemic nuclei of the intramyocardial arteries were increased 
first in the septum, and at day three, also in the left ventricle. CD68-positive macrophages were 
abundant in the septum in the hearts with AVO. All selected gene expressions associated with 
cardiac insufficiency, including ANP, MMP9, TGFβ and YKL40, were increased early after AVO. 
12
ANP represents compensation of congestive heart failure due to its vasodilating, antiproliferative, 
and neurohumoral-modulating capacity.7 Along with MMP9 and growth factors such as TGFβ, 
YKL40 expression is a highly promising mediator of tissue remodeling associated with ischemia 
reperfusion injury.3,8 Intramyocardial arteries are susceptible to early changes as reflected by 
increased expressions of parameters associated with the onset of cardiac insufficiency.  
Acute right heart dysfunction is an important etiological factor of heart failure after surgery,1,2 and 
up to 40% of patients with right ventricle failure experience ongoing right-sided heart volume-
overload.4 Translational research including an animal model of acute right ventricle volume-
overload has increased awareness of the molecular mechanisms involved during AVO. 9 In this 
study, AVO due to surgically-induced aortocaval fistula rendered the myocardium susceptible to 
acute increased oxygen consumption thus simulating the clinical concept of AVO after surgery; 
AVO triggered the onset of cardiac remodeling leading to cardiac failure. ANP was increased at day 
one, indicating that early cardiac failure occurred after AVO. After three days, the acute markers for 
early heart failure subsided, and an adaptive phase was histologically appreciated as observed by a 
stabilization of relative ischemia in the septum and both ventricles.  
The intramyocardial arteries of the hearts with surgical AVO developed ischemic-like changes 
including ischemic smooth muscle cell nuclei consistent with sharp-edged dark nuclei. 
Concomitantly, edematous and vacuolated nuclei were abundant at day one, but decreased 
significantly at day three. As observed by the relative number of ischemic nuclei of the 
intramyocardial arteries, the presence of ischemic-like and vacuolated cell nuclei suggests that early 
changes were subtle in the hearts that already had AVO at day one. Interestingly, the septum 
seemed to reflect the early volume-overload of the right atrium and ventricle. Indeed, the septum 
has been shown to be susceptible to acute right-sided heart volume-overload.10 Early 
pharmacological interventions could therefore be primarily aimed at preserving the tissue integrity 
of the septum rather than increasing right-sided cardiac output.  
Cardiac inflammation occurs as an early response to acute heart failure. 11 Macrophages, as detected 
by CD68 immunostaining, infiltrate the periadventitia of the intramyocardial arteries together with 
the myocardium. Macrophage activity after acute inflammation occurs as a biphasic response 
changing from the M1 to the M2 macrophage phenotype.12,13 The pro-inflammatory M1 
macrophages give way to the anti-inflammatory M2 macrophages enabling the induction of fibrosis 
during the proliferative cardiac remodeling phase.14 
13
YKL40 contributes to tissue remodeling, although its exact pathogenetic role is still poorly 
understood.12,15 YKL40 is a chitinase-like glycoprotein which impacts cell proliferation, 
differentiation, inflammation, and remodeling of the extracellular matrix.15 Increased YKL40 and 
MMP activation has been shown to induce pro-inflammatory and pro-fibrotic cytokines after 
ischemia-reperfusion injury.12 In addition, YKL40 regulates the accumulation of T cells and 
activated macrophages.15  
Activation of T cells also induces cytokines that regulate TGFβ, and an enhanced TGFβ expression 
indicates progressive right ventricle volume-overload including septal shift, subendocardial fibrosis 
and cardiomyocyte apoptosis.10 Susceptibility to intramyocardial artery edema may be associated 
with endothelial activity through syndecan-1 and integrins, suggesting the presence of TGFβ and 
YKL40 activation that leads eventually to tissue fibrogenesis and angiogenesis.16 The endothelial 
cell lining of the intramyocardial arteries is the primary target after acute volume-overload upon 
altered microcirculation of the heart, and therefore markers of endothelial activity such as YKL40 
may be increased. Subsequently, endothelial activity may attract inflammatory cells such as 
macrophages that interact with MMP9 and TGFβ.  
A limitation of this study is that we did not study cardiac function. Creation of a surgical 1.0-1.2-
mm long arteriovenous fistula was previously described by Stumpe et al.,17 and most other models 
are based on a small aortocaval fistula created by needle puncture. 18 These models are excellent for 
studying the progression of chronic cardiac failure,18,19 and demonstration of cardiac function is 
important to describe these models. Many studies have reported on left-sided ventricle-overload, 
however this may not be directly extrapolated to congestive heart failure induced by AVO, and 
different cell signaling pathways and temporal patterns of cardiac remodeling may be expected. 18 
As clinical scenarios such as AVO have been poorly studied, a significant 5-mm- long 
arteriovenous fistula was created, and a visual increase in blood flow of the vena cava was evident 
immediately after suture of the fistula, thus confirming the acute increase in circulating blood flow.  
 
 
 
 
14
CONCLUSIONS  
 
Volume-overload ultimately leads to the development of eccentric cardiac hypertrophy. 11 Low 
myocardial perfusion pressure during AVO initiates early left ventricular dysfunction due to acute 
congestion of the heart and contributes to cardiac remodeling.5 Taken together, surgical AVO 
triggers early myocardial ischemia; therefore treatment aimed at protecting intramyocardial arteries 
may provide a novel strategy against global cardiac detrition after AVO.  
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